| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1025485907 |
| P356 | DOI | 10.1007/S11914-010-0014-3 |
| P698 | PubMed publication ID | 20425612 |
| P2093 | author name string | Dana Gaddy | |
| Tristan W Fowler | |||
| Kristy M Nicks | |||
| P2860 | cites work | Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis 1 | Q22306225 |
| Regulation of osteoblastogenesis and osteoclastogenesis by the other reproductive hormones, Activin and Inhibin | Q24633744 | ||
| FSH directly regulates bone mass | Q28512745 | ||
| Possible neuroendocrine role for oxytocin in bone remodeling | Q28567824 | ||
| Estrogen deficiency, obesity, and skeletal abnormalities in follicle-stimulating hormone receptor knockout (FORKO) female mice | Q28590055 | ||
| The endocrinology of the menopause | Q33694903 | ||
| Sex steroids and the construction and conservation of the adult skeleton | Q34131889 | ||
| Fracture risk after bilateral oophorectomy in elderly women. | Q34195112 | ||
| Neuroendocrine aging in men. Andropause and somatopause | Q34380984 | ||
| Endocrine causes of age-related bone loss and osteoporosis. | Q34539034 | ||
| Hormonal changes in the menopause transition | Q34644005 | ||
| The role of estrogens in men and androgens in women. | Q35108989 | ||
| Molecular biology of inhibin action | Q35866885 | ||
| Osteoclast-derived activity in the coupling of bone formation to resorption. | Q36032429 | ||
| Pituitary actions of ligands of the TGF-beta family: activins and inhibins | Q36555335 | ||
| Regulation of bone turnover by sex steroids in men | Q37172776 | ||
| Oxytocin is an anabolic bone hormone | Q37182727 | ||
| Oxytocin is required for nursing but is not essential for parturition or reproductive behavior | Q37265416 | ||
| Progesterone receptors are expressed in human osteoblast-like cell lines and in primary human osteoblast cultures | Q38288435 | ||
| Follicle-stimulating hormone does not impact male bone mass in vivo or human male osteoclasts in vitro | Q38291172 | ||
| Inhibin suppresses and activin stimulates osteoblastogenesis and osteoclastogenesis in murine bone marrow cultures | Q38293716 | ||
| Evidence for direct effects of prolactin on human osteoblasts: Inhibition of cell growth and mineralization | Q39861165 | ||
| Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio | Q40029157 | ||
| Functional oxytocin receptors discovered in human osteoblasts | Q40932693 | ||
| Progesterone upregulates TGF-b isoforms (b1, b2, and b3) expression in normal human osteoblast-like cells | Q44087410 | ||
| The association of endogenous hormone concentrations and bone mineral density measures in pre- and perimenopausal women of four ethnic groups: SWAN. | Q44309056 | ||
| Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN. | Q44429740 | ||
| Elevated aromatase expression in osteoblasts leads to increased bone mass without systemic adverse effects | Q46102174 | ||
| Bone turnover across the menopause transition: correlations with inhibins and follicle-stimulating hormone | Q46282443 | ||
| Ovarian aging and bone metabolism in menstruating women aged 35-50 years | Q46722132 | ||
| Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone | Q47982658 | ||
| Bone loss goes beyond estrogen | Q48505837 | ||
| Endocrine defects in mice carrying a null mutation for the progesterone receptor gene | Q48619538 | ||
| Endocrine changes of the perimenopause | Q48924897 | ||
| Osteoblasts are a new target for prolactin: analysis of bone formation in prolactin receptor knockout mice. | Q51092454 | ||
| Human osteoclasts express oxytocin receptor | Q58327160 | ||
| Serum concentrations of dimeric inhibins, activin A, gonadotrophins and ovarian steroids during the menstrual cycle in older women | Q63359760 | ||
| Reproductive aging: accelerated ovarian follicular development associated with a monotropic follicle-stimulating hormone rise in normal older women | Q71441833 | ||
| Bone turnover markers and bone density across the menopausal transition | Q71477234 | ||
| Role of osteoblasts in hormonal control of bone resorption - a hypothesis | Q71614035 | ||
| Effects of acute and long-term administration of prolactin on bone 45Ca uptake, calcium deposit, and calcium resorption in weaned, young, and mature rats | Q73044999 | ||
| Sex steroids and bone | Q74124341 | ||
| Female reproductive aging is marked by decreased secretion of dimeric inhibin | Q77909547 | ||
| Androgens and bone | Q79811504 | ||
| Aromatase expression in osteoarthritic and osteoporotic bone | Q81361016 | ||
| FSH versus estrogen: who's guilty of breaking bones? | Q83297326 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 60-67 | |
| P577 | publication date | 2010-06-01 | |
| P1433 | published in | Current osteoporosis reports | Q26841869 |
| P1476 | title | Reproductive hormones and bone | |
| P478 | volume | 8 |
| Q90262277 | Bone loss caused by dopaminergic degeneration and levodopa treatment in Parkinson's disease model mice |
| Q37022656 | Cichlid fishes as a model to understand normal and clinical craniofacial variation |
| Q34064555 | Control of bone resorption by semaphorin 4D is dependent on ovarian function |
| Q36538137 | Different effects of an extended photoperiod treatment on growth, gonadal function, and condition of hair coats in Thoroughbred yearlings reared under different climate conditions |
| Q64104002 | Effect of risperidone on proliferation and apoptosis of MC3T3-E1 cells |
| Q35010146 | Effect of the combined extracts of herba epimedii and fructus ligustri lucidi on sex hormone functional levels in osteoporosis rats |
| Q92259566 | Evidence for Gender-Specific Bone Loss Mechanisms in Periprosthetic Osteolysis |
| Q35809844 | FOXL2 modulates cartilage, skeletal development and IGF1-dependent growth in mice |
| Q36588295 | Failure to generate bone marrow adipocytes does not protect mice from ovariectomy-induced osteopenia |
| Q35737371 | Follicle-Stimulating Hormone Increases the Risk of Postmenopausal Osteoporosis by Stimulating Osteoclast Differentiation |
| Q35738907 | Follistatin-like 3 is a mediator of exercise-driven bone formation and strengthening. |
| Q43714450 | Further evidence that FSH causes bone loss independently of low estrogen |
| Q34392597 | Increased PTHrP and Decreased Estrogens Alter Bone Turnover but Do Not Reproduce the Full Effects of Lactation on the Skeleton |
| Q37080473 | Inhibin A enhances bone formation during distraction osteogenesis |
| Q47945429 | Prolactin levels are associated with a pro-inflammatory body mass distribution among women with systemic lupus erythematosus. |
| Q36736515 | Serum sex steroid levels and longitudinal changes in bone density in relation to the final menstrual period |
| Q35698885 | The Daily Profiles of Circulating AMH and INSL3 in Men are Distinct from the Other Testicular Hormones, Inhibin B and Testosterone |
| Q51312686 | The effect of long-term nicotine exposure on bone mineral density and oxidative stress in female Swiss Albino rats. |
| Q35496098 | Thiazolidinediones on PPARγ: The Roles in Bone Remodeling |
| Q88379121 | Tumor necrosis factor alfa and interleukin 1 alfa induced phosphorylation and degradation of inhibitory kappa B alpha are regulated by estradiol in endometrial cells |
Search more.